# Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease

> **NCT07208344** · EARLY_PHASE1 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer Disease (AD)

## Interventions

- **BIOLOGICAL:** Intravenous infusion of mononuclear cells from umbilical cord blood
- **DRUG:** Conventional medical treatment：donepezil, rivastigmine or galantamine

## Key facts

- **NCT ID:** NCT07208344
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07208344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07208344, "Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07208344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*